Figure 1From: Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma ALK rearrangement as visualised by fluorescence in situ hybridization (FISH). FISH image of ALK re-arrangement using the Vysis (Abbott) LSI ALK dual color, break apart rearrangement probe (Abbott molecular, Illinois).Back to article page